GS
SCPH

GTS Securities’s scPharmaceuticals SCPH Stock Holding History

GTS Securities’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,696
Closed -$83.3K – 1740
2025
Q3 		$83.3K Buy
+14,696
New +$75.3K ﹤0.01% 1361

GTS Securities's SCPH Position: Q4 2025 in Review

GTS Securities sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 14,696 shares — an estimated $83.3K sold.

GTS Securities first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $83.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • GTS Securities reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 14,696 scPharmaceuticals shares in Q4 2025, an estimated $83.3K.
  • GTS Securities first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
  • GTS Securities's scPharmaceuticals position peaked at $83.3K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.